TScan Therapeutics, Inc. (TCRX) Interest Expense USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
TScan Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2022 to 2024.
  • TScan Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $959 K, a 0.31% increase year-over-year.
  • TScan Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $3.76 M.
  • TScan Therapeutics, Inc. annual Interest Expense for 2023 was $3.76 M, a 220% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.76 M $959 K +$3 K +0.31% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $3.76 M $852 K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $982 K +$781 K +389% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $969 K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $956 K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 $201 K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.